By surfacing conversational, behavioral, and environmental insights at the point of care — and enabling data-driven operational decisions — AI has the power to transform individual patient experiences and drive systemic improvements in care quality and efficiency. The post The New Role of Engagement: Surfacing Insights at the Point of Care and Beyond appeared first…
Joining Matthew Holt (@boltyboy) on #THCBGang on Thursday November 14 at 1PM PT 4PM ET. Today we have also a special guest – former Permanente Medical Group CEO Dr Robbie Pearl @robertpearlmd. Robbie has been diving into AI in his latest book ChatGPT-MD and we’ll be chatting about that as well as his forecasts for health…
AstraZeneca’s EsoBiotec acquisition is the latest in a series of deals struck by the pharma giant to secure a place in the next wave of cell therapies for cancer and immune-mediated diseases. EsoBiotec’s allogeneic cell therapies are made by the in vivo reprogramming of a patient’s immune cells. The post AstraZeneca Aims to Make Cell…
The National Institutes of Health’s sweeping cuts of grants that fund scientific research are inflicting pain almost universally across the U.S., including in most states that backed President Donald Trump in the 2024 election. A KFF Health News analysis underscores that the terminations are sparing no part of the country, politically or geographically. About 40%…
“On Feb. 25, I voted yes on a budget resolution that protects Social Security, Medicare, and Medicaid while cutting some spending elsewhere.” Rep. Nick LaLota (R-N.Y.), in a YouTube video posted March 4, 2025 On Feb. 25, Rep. Nick LaLota (R-N.Y.) voted in favor of a House budget resolution that calls for sharp cuts in…
That is the question asked in a new paper by Enright, et al. (2025). The authors use the Tufts Medical Center Specialty Drug Evidence and Coverage (SPEC) database current as of August 2023. This database contains publicly available specialty pharmacy coverage decisions as issued by 18 large US commercial health plans, which—collectively—cover 200m people (i.e.,…
Try a variety of LLM-based tools yourself. Understand the risks, limitations, and who is working on putting quality frameworks and guardrails in place. Engage your employees and partners in discussions about what might now be possible. The post A CEO’s Guide to AI Exploration: Transforming Organizations and Mindsets appeared first on MedCity News.
Mimi Winsberg, M.D., discusses study indicating that LLMs can help clinicians triage patients with suicidal ideation
That is the title of a new FTI Consulting white paper co-authored with Kyi-Sin Than. The abstract is below. In October 2023, ICER released a special assessment aimed at influencing CMS drug price negotiations for two direct-acting oral anticoagulants (DOACs) selected in the first round of Inflation Reduction Act (IRA) price negotiations in 2024: Eliquis®…
Despite the evidence of their positive impact, pharmacists today lack the ability to reliably bill for clinical services as healthcare providers. It is important that payers provision pharmacists, include them in networks, and enable reimbursement through traditional billing models. The post Pharmacists Embrace Provider Status in Healthcare, but Hurdles Remain appeared first on MedCity News.